To achieve the maximal renoprotective benefits of metformin, it may be necessary to use metformin in combination with SGLT2 (Sodium-Glucose co-transporter-2) inhibitors or incretin-based therapies at an early stage of DKD [19]. This evidence concerns the gene GCG and diabetic kidney disease.